J2795 HCPCS code: Injection, ropivacaine hydrochloride, 1 mg
J2795 is the HCPCS Level II code for injection, ropivacaine hydrochloride, 1 mg. In 2024 Medicare paid an average of $0.05 per service for J2795 across 712,075 services. Its Medicare coverage code is C (Carrier judgment): Coverage is decided by the Medicare contractor (MAC) case by case. The NCCI unit limit is 2400 per day on outpatient hospital claims. Medicare volume rose 9% from 2022 to 2024 (653,869 to 712,075 services). In 2024, about 616 clinicians billed Medicare for J2795 for 9,972 beneficiaries; Arizona, California, Michigan accounted for 65% of services.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | C — Carrier judgment |
| Pricing indicator | 51 — Drug or biological (priced per ASP/average sales price rules) |
| BETOS category | O1E — Other drugs |
| Added | 2001-01-01 |
| Last action effective | 2001-01-01 |
Who bills J2795 (2024)
| Measure | Value |
|---|---|
| Clinicians billing (by place of service) | 616 |
| Medicare beneficiaries | 9,972 |
| States with claims | 30 |
| Share of services in top 3 states (Arizona, California, Michigan) | 65% |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for J2795, 2022–2024
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2022 | 653,869 | 18,318 | $0.07 | $0.06 |
| 2023 | 729,340 | 17,396 | $0.07 | $0.06 |
| 2024 | 712,075 | 9,972 | $0.07 | $0.05 |
States with the most J2795 services (2024)
| State | Services | Avg. paid |
|---|---|---|
| Arizona | 218,450 | $0.05 |
| California | 160,511 | $0.05 |
| Michigan | 83,174 | $0.05 |
| Kansas | 66,233 | $0.05 |
| North Carolina | 48,243 | $0.05 |
NCCI unit limits (MUE)
| Claim type | Max units per day | Rationale |
|---|---|---|
| outpatient hospital claims | 2400 | Clinical: Data |
| practitioner claims | 200 | Prescribing Information |
What changed for J2795
- 2001-01-01: J2795 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J2795?
J2795 is the HCPCS Level II code for injection, ropivacaine hydrochloride, 1 mg. Short descriptor: "Ropivacaine hcl injection".
How much does Medicare pay for J2795?
In 2024, the average Medicare payment was $0.05 per service (average allowed $0.07).
Does Medicare cover J2795?
Coverage code C — Carrier judgment. Coverage is decided by the Medicare contractor (MAC) case by case.
How many units of J2795 can be billed per day?
2400 on outpatient hospital claims; 200 on practitioner claims (NCCI medically unlikely edits).
Related J27 codes
- J2700 — Injection, oxacillin sodium, up to 250 mg
- J2704 — Injection, propofol, 10 mg
- J2710 — Injection, neostigmine methylsulfate, up to 0.5 mg
- J2720 — Injection, protamine sulfate, per 10 mg
- J2724 — Injection, protein c concentrate, intravenous, human, 10 iu
- J2725 — Injection, protirelin, per 250 mcg
- J2730 — Injection, pralidoxime chloride, up to 1 gm
- J2760 — Injection, phentolamine mesylate, up to 5 mg
- J2765 — Injection, metoclopramide hcl, up to 10 mg
- J2770 — Injection, quinupristin/dalfopristin, 500 mg (150/350)
- J2777 — Injection, faricimab-svoa, 0.1 mg
- J2778 — Injection, ranibizumab, 0.1 mg
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J2795
- Watch J2795 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J2795
Sources: CMS HCPCS Level II release October 2025; CMS DMEPOS fee schedule; CMS NCCI MUE tables; CMS Medicare utilization (physician and DME supplier files); CMS Medicare Coverage Database articles. Fees are Medicare allowables, not commercial rates. Not billing or legal advice.